You are here: Industry Insights > Gennova

News List

HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India pharmaceutical-technology
May 06, 2021
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in the country.
Efforts to ramp up production of COVID-19 vaccines, easy availability underway: Renu Swarup expresspharma
April 23, 2021
The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out into the immunisation programme without any time lag, she said.
Four more COVID-19 vaccines in pipeline: Health Secretary expresspharma
January 14, 2021
Zydus Cadila, Sputnik V, Biological E and Gennova are in advanced clinical trials in India, some of them likely to approach drug controller for EUA, said Bhushan.
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials expresspharma
December 14, 2020
It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Science & Technology.
PM to visit Serum Institute of India in Pune on Nov 28 expresspharma
November 27, 2020
The CDSCO has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms.
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate expresspharma
July 27, 2020
DBT-BIRAC has facilitated the establishment of ‘first-of-its-kind’ mRNA-based vaccine manufacturing platform in India. It has provided seed funding for the development of Gennova’s novel self-amplifying mRNA-based vaccine candidate for COVID19.